Munich - Delayed Quote EUR

Bristol-Myers Squibb Co (BRM.MU)

56.50

+0.19

+(0.34%)

At close: January 30 at 8:04:11 AM GMT+1

Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?

Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks 12 hours ago

CELG-RT
Bristol Myers Squibb (BMY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Bristol Myers (BMY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 14 hours ago

CELG-RT

QGEN
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks 15 hours ago

GH

CELG-RT
Why Bristol-Myers Squibb Company (BMY) Is the Best Blue Chip Stock to Buy Under $100?

We recently compiled a list of the 12 Best Blue Chip Stocks to Buy Under $100. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best blue chip stocks to buy under $100. Blue chip stocks have long been considered the gold standard of investments, offering […]

Insider Monkey yesterday

CELG-RT

^GSPC
Bristol-Myers Squibb (BMY): Cramer’s Old-School Move for DeepSeek Market Jitters

We recently published a list of Jim Cramer Breaks Silence On DeepSeek AI Sell-Off & Discusses These 12 Stocks. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other stocks discussed by Jim Cramer with insights on the DeepSeek AI sell-off. On the day that Wall […]

Insider Monkey yesterday

CELG-RT
Bristol-Myers Squibb Insider Ups Holding During Year

Looking at Bristol-Myers Squibb Company's ( NYSE:BMY ) insider transactions over the last year, we can see that...

Simply Wall St. yesterday

BMY

CELG-RT
3 Cheap Dividend Stocks That Pay More Than Double the S&P 500 Average

The stocks in the S&P 500, for instance, average a yield of just 1.3%. It would mean you have to invest around $77,000 in S&P 500 stocks to expect to collect just $1,000 in dividends over the course of a full year. The good news, however, is that there are quality stocks that pay yields of well over double that rate, and they aren't risky or expensive investments, either.

Motley Fool yesterday

^GSPC

TGT

SU
Is Bristol-Myers Squibb Company (BMY) the Safe Stock to Buy for the Long Term in 2025?

We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other safe stocks to buy for the long term in 2025. The US stock market is often regarded as one […]

Insider Monkey yesterday

CELG-RT

^GSPC
Drugmakers Show Restraint on Price Increases in New Trump Era

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a median 4% at the start of this year. The modest size of the annual increases could help companies avoid criticism of gouging from President Trump while seeking his administration’s support for such priorities as taking aim at the rebates given to middlemen and altering a federal program providing discounts to certain hospitals. Last year’s median price increase was 4.5%.

The Wall Street Journal 2 days ago

PFE

AMGN

UTHR
Why the Market Dipped But Bristol Myers Squibb (BMY) Gained Today

The latest trading day saw Bristol Myers Squibb (BMY) settling at $60.62, representing a +1.59% change from its previous close.

Zacks 3 days ago

CELG-RT
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know

Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks 3 days ago

CELG-RT
Bristol Myers Squibb Presents Results from CheckMate -8HW Analysis Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) Compared to Opdivo Monotherapy...

PRINCETON, N.J., January 25, 2025--BMS Presents Results from CheckMate -8HW

Business Wire 5 days ago

BMY

CELG-RT
Is Bristol-Myers Squibb Company (BMY) the Best Stock to Invest In For Steady Dividends?

We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other dividend stocks. Dividend stocks, while popular among investors, have been underperforming for a while. Dan Lefkovitz, a strategist at Morningstar Indexes, […]

Insider Monkey 8 days ago

CELG-RT
Jim Cramer Says Bristol-Myers Squibb Company (BMY)’s ‘Got The One That Everybody Is Buzzing About’

We recently compiled a list of the Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other stocks Jim Cramer recently discussed. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented […]

Insider Monkey 9 days ago

CELG-RT
Why Is Bristol-Myers Squibb Company (BMY) Among the Best High-Yield Dividend Stocks to Invest In?

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other high-yield dividend stocks. Dividend stocks have been investors’ favorites for a long time now. Over the years, these equities have performed […]

Insider Monkey 9 days ago

CELG-RT
Bristol-Myers Squibb Company (NYSE:BMY) is largely controlled by institutional shareholders who own 77% of the company

Key Insights Institutions' substantial holdings in Bristol-Myers Squibb implies that they have significant influence...

Simply Wall St. 9 days ago

BMY

CELG-RT
Bristol-Myers Squibb Company (BMY): A Bull Case Theory

We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BMY. Bristol-Myers Squibb Company (BMY)’s share was trading at $56.29 as of Jan 17th. BMY’s trailing and forward P/E were 22.79 and 7.93 respectively according to Yahoo Finance. Bristol […]

Insider Monkey 10 days ago

CELG-RT
Why Bristol-Myers Squibb (BMY) Is One of the Best Cheap Stocks to Buy for 2025?

We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best cheap stocks to buy for 2025. The U.S. consumer prices report released this week revealed a less-than-expected increase in December, signaling […]

Insider Monkey 12 days ago

CELG-RT
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

The Department of Health and Human Services, through the Centers for Medicare & Medicaid Services, announced the selection of 15 additional drugs covered under Medicare Part D for price negotiations. In accordance with the Inflation Reduction Act, the negotiations with participating drug companies for these 15 drugs will occur in 2025 and any negotiated prices will become effective in 2027, the agency said in a statement. The selected drug list for the second cycle of negotiations is: Novo Nordi

TipRanks 12 days ago

NONOF

NVO

BMY
Bristol Myers Squibb (BMY) Stock Dips While Market Gains: Key Facts

The latest trading day saw Bristol Myers Squibb (BMY) settling at $56.29, representing a -0.16% change from its previous close.

Zacks 13 days ago

CELG-RT

^GSPC

Performance Overview

Return	BRM.MU	S&P 500
YTD	+3.87%	+2.78%
1-Year	+29.99%	+23.20%
3-Year	+12.11%	+36.99%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bristol-Myers Squibb Co (BRM.MU)

Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?

Bristol Myers Squibb (BMY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Why Bristol-Myers Squibb Company (BMY) Is the Best Blue Chip Stock to Buy Under $100?

Bristol-Myers Squibb (BMY): Cramer’s Old-School Move for DeepSeek Market Jitters

Bristol-Myers Squibb Insider Ups Holding During Year

3 Cheap Dividend Stocks That Pay More Than Double the S&P 500 Average

Is Bristol-Myers Squibb Company (BMY) the Safe Stock to Buy for the Long Term in 2025?

Drugmakers Show Restraint on Price Increases in New Trump Era

Why the Market Dipped But Bristol Myers Squibb (BMY) Gained Today

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know

Bristol Myers Squibb Presents Results from CheckMate -8HW Analysis Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) Compared to Opdivo Monotherapy...

Is Bristol-Myers Squibb Company (BMY) the Best Stock to Invest In For Steady Dividends?

Jim Cramer Says Bristol-Myers Squibb Company (BMY)’s ‘Got The One That Everybody Is Buzzing About’

Why Is Bristol-Myers Squibb Company (BMY) Among the Best High-Yield Dividend Stocks to Invest In?

Bristol-Myers Squibb Company (NYSE:BMY) is largely controlled by institutional shareholders who own 77% of the company

Bristol-Myers Squibb Company (BMY): A Bull Case Theory

Why Bristol-Myers Squibb (BMY) Is One of the Best Cheap Stocks to Buy for 2025?

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

Bristol Myers Squibb (BMY) Stock Dips While Market Gains: Key Facts

Performance Overview